Top

Published in:

01-02-2014 | Original Article

The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3

Authors: Yanmin Zhang, Juanli Wang, Suer Chang, Nan Zhou, Haijian Xing, Lei Wang, Chen Huang, Aiqun Ma, Christopher L.-H. Huang, Ming Lei, James A. Fraser

Published in: Pediatric Cardiology | Issue 2/2014

Abstract

Mutations of the SCN5A gene are associated with several arrhythmic syndromes including the Brugada syndrome, conduction disease, long QT syndrome type 3 (LQT3), atrial fibrillation, and dilated cardiomyopathy. We report LQT3 associated with an A1180V cardiac sodium channel mutation, previously associated with cardiac conduction block, and dilated cardiomyopathy in three generations of a Chinese family. Clinical, electrocardiographic (ECG), and echocardiographic examination was followed by direct sequencing of SCN5A and HERG to screen genomic DNA from blood samples. The proband presented with multiple syncopes from the age of 7 years and was found to share a mutation with two other members of his family. Continuous ECG monitoring after presentation showed prolonged QTc and biphasic T waves, multiple episodes of ventricular tachycardia and torsades de pointes. The other two mutation carriers showed ECG features of LQT3 without clinical symptoms. Transthoracic echocardiography showed normal cardiac structure in all three mutation carriers. This study shows LQT3 features associated with an A1180V cardiac sodium channel mutation, expanding the spectrum of phenotypes resulting from this mutation in which biophysical study has shown a persistent late Na⁺ current.

Akai J, Makita N, Sakurada H, Shirai N, Ueda K, Kitabatake A et al (2000) A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett 479(1–2):29–34CrossRefPubMed

Amin AS, Asghari-Roodsari A, Tan HL (2010) Cardiac sodium channelopathies. Pflugers Arch 460(2):223–237PubMedCentralCrossRefPubMed

Bennett PB, Yazawa K, Makita N, George AL Jr (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature 376(6542):683–685CrossRefPubMed

Benson DW, Wang DW, Dyment M, Knilans TK, Fish FA, Strieper MJ et al (2003) Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 112(7):1019–1028PubMedCentralCrossRefPubMed

Bezzina C, Veldkamp MW, van Den Berg MP, Postma AV, Rook MB, Viersma JW et al (1999) A single Na⁺ channel mutation causing both long-QT and Brugada syndromes. Circ Res 85(12):1206–1213CrossRefPubMed

Clancy CE, Rudy Y (2002) Na⁺ channel mutation that causes both Brugada and long-QT syndrome phenotypes: a simulation study of mechanism. Circulation 105(10):1208–1213PubMedCentralCrossRefPubMed

Ge J, Sun A, Paajanen V, Wang S, Su C, Yang Z et al (2008) Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 1(2):83–92CrossRefPubMed

Groenewegen WA, Firouzi M, Bezzina CR, Vliex S, van Langen IM, Sandkuijl L et al (2003) A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ Res 92(1):14–22CrossRefPubMed

Head CE, Balasubramaniam R, Thomas G, Goddard CA, Lei M, Colledge WH et al (2005) Paced electrogram fractionation analysis of arrhythmogenic tendency in DeltaKPQ Scn5a mice. J Cardiovasc Electrophysiol 16(12):1329–1340CrossRefPubMed

10.

Keller DI, Acharfi S, Delacretaz E, Benammar N, Rotter M, Pfammatter JP et al (2003) A novel mutation in SCN5A, delQKP 1507–1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation. J Mol Cell Cardiol 35(12):1513–1521CrossRefPubMed

11.

Lupoglazoff JM, Cheav T, Baroudi G, Berthet M, Denjoy I, Cauchemez B et al (2001) Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res 89(2):E16–E21CrossRefPubMed

12.

Martin CA, Zhang Y, Grace AA, Huang CL (2010) In vivo studies of Scn5a +/− mice modeling Brugada syndrome demonstrate both conduction and repolarization abnormalities. J Electrocardiol 43(5):433–439PubMedCentralCrossRefPubMed

13.

Martin CA, Grace AA, Huang CL (2011) Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model. Am J Physiol Heart Circ Physiol 300(2):H605–H616PubMedCentralCrossRefPubMed

14.

McNair WP, Ku L, Taylor MR, Fain PR, Dao D, Wolfel E et al (2004) SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110(15):2163–2167CrossRefPubMed

15.

Mohler PJ, Rivolta I, Napolitano C, LeMaillet G, Lambert S, Priori SG et al (2004) Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci USA 101(50):17533–17538PubMedCentralCrossRefPubMed

16.

Nuyens D, Stengl M, Dugarmaa S, Rossenbacker T, Compernolle V, Rudy Y et al (2001) Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7(9):1021–1027CrossRefPubMed

17.

Remme CA, Wilde AA (2008) SCN5A overlap syndromes: no end to disease complexity? Europace 10(11):1253–1255CrossRefPubMed

18.

Remme CA, Verkerk AO, Nuyens D, van Ginneken AC, van Brunschot S, Belterman CN et al (2006) Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114(24):2584–2594CrossRefPubMed

19.

Shi R, Zhang Y, Yang C, Huang C, Zhou X, Qiang H et al (2008) The cardiac sodium channel mutation delQKP 1507–1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death. Europace 10(11):1329–1335PubMedCentralCrossRefPubMed

20.

Syrris P, Murray A, Carter ND, McKenna WM, Jeffery S (2001) Mutation detection in long QT syndrome: a comprehensive set of primers and PCR conditions. J Med Genet 38(10):705–710PubMedCentralCrossRefPubMed

21.

Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA (2003) Genetic control of sodium channel function. Cardiovasc Res 57(4):961–973CrossRefPubMed

22.

Tian XL, Yong SL, Wan X, Wu L, Chung MK, Tchou PJ et al (2004) Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc Res 61(2):256–267PubMedCentralCrossRefPubMed

23.

Tian XL, Cheng Y, Zhang T, Liao ML, Yong SL, Wang QK (2007) Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S. Biochem Biophys Res Commun 352(4):879–883PubMedCentralCrossRefPubMed

24.

Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR (2000) Two distinct congenital arrhythmias evoked by a multidysfunctional Na⁺ channel. Circ Res 86(9):E91–E97CrossRefPubMed

25.

Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL et al (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80(5):805–811CrossRefPubMed

26.

Wang DW, Desai RR, Crotti L, Arnestad M, Insolia R, Pedrazzini M et al (2007) Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115(3):368–376CrossRefPubMed

27.

Yong SL, Ni Y, Zhang T, Tester DJ, Ackerman MJ, Wang QK (2007) Characterization of the cardiac sodium channel SCN5A mutation, N1325S, in single murine ventricular myocytes. Biochem Biophys Res Commun 352(2):378–383PubMedCentralCrossRefPubMed

28.

Zimmer T, Surber R (2008) SCN5A channelopathies—an update on mutations and mechanisms. Prog Biophys Mol Biol 98(2–3):120–136CrossRefPubMed

Title: The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3
Authors: Yanmin Zhang
Juanli Wang
Suer Chang
Nan Zhou
Haijian Xing
Lei Wang
Chen Huang
Aiqun Ma
Christopher L.-H. Huang
Ming Lei
James A. Fraser
Publication date: 01-02-2014
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 2/2014
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-013-0773-6

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

The SCN5A Mutation A1180V is Associated With Electrocardiographic Features of LQT3

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Evaluation of Cardiac Functions of Patients with Benign Joint Hypermobility Syndrome

Effect of Antiepilepsy Drug Therapy on Ventricular Function in Children With Epilepsy: A Tissue Doppler Imaging Study

Low Incidence of Arrhythmias in the Right Ventricular Infundibulum Sparing Approach to Tetralogy of Fallot Repair

The Spectrum of Congenital Heart Disease and Outcomes After Surgical Repair Among Children With Turner Syndrome: A Single-Center Review

Long-Term Follow-up Assessment After the Arterial Switch Operation for Correction of Dextro-Transposition of the Great Arteries by Means of Exercise Myocardial Perfusion-Gated SPECT

How Not to Tell Parents About Their Child’s New Diagnosis of Congenital Heart Disease: An Internet Survey of 841 Parents

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page